Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Charcot-Marie-Tooth Disease Type 4H Resulting from Compound Heterozygous Mutations in FGD4 from Nonconsanguineous Korean Families.
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
The Impact of a Patient Support Program for Multiple Sclerosis on Patient Satisfaction and Subjective Health Status.
Teaching NeuroImages: MRI time lag with acute disseminated encephalomyelitis.
Pain mechanisms in multiple sclerosis.
Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis.
Polymorphisms of paraoxonase 1 and 2 genes and the risk of multiple sclerosis in the Polish population.
Tysabri screening test may be unreliable
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action.
Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique.
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Fenofibrate Inhibited the Differentiation of T Helper 17 Cells In Vitro.
Susceptibility phase imaging with improved image contrast using moving window phase gradient fitting and minimal filtering.
Reibergram and oligoclonal bands in diagnosis of multiple sclerosis.
Neuropathic pruritus (itch) in neuromyelitis optica.
Do cortical lesions help us to distinguish MS from NMO?
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS.
Multiple sclerosis and palliative care - perceptions of severely affected multiple sclerosis patients and their health professionals: a qualitative study.
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Neuroprotection With Phenytoin in Optic Neuritis
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
Generation and characterization of spiking and non-spiking oligodendroglial progenitor cells from embryonic stem cells.
[Differential diagnosis of late-stage neuroborreliosis with affection of the central nervous system.]

Pages